AFR Winner

Employees: 30-99

Ellume’s bespoke system simplifies the delivery of a lab-accurate diagnostic result and other clinical decision making tools, through the combination of our patented technology, innovative cartridge system and paired software. It uses inexpensive materials that can be manufactured on a large scale – creating a commercially viable solution for unmet clinical needs. We innovated across multiple disciplines, including mechanical engineering, nanotechnology and immunoassay technology. The innovation has three elements:

1. Multi-Quantum Dot particles, our patented marker system, uses an ultra-bright fluorescent reporting system, helping to simplify a highly technical lab-based diagnostic process without compromising the accuracy of the test.

2. A highly sensitive biosensor that is integrated with a modified immunoassay format into a single-use test cartridge and unique sample collection and processing device. The cartridge contains everything to analyse the sample, compute a result and transmit it to the user.

3. User-friendly software is used in conjunction with the cartridge, to display a user-guide to minimise error, and eventually assist clinics and hospitals to move to a cloud-based data collection system and create efficiencies in patient care.